Intercure Ltd (INCR)

$0.91 +0.01 (0.97%)
Market Cap 40.97M
Revenue (ttm) 66.28M
Net Income (ttm) -18.32M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.64%
Debt to Equity Ratio 0.22
Volume 64,600
Avg Vol 42,996
Day's Range N/A - N/A
Shares Out 45.57M
Stochastic %K 85%
Beta 1.22
Analysts Strong Buy
Price Target $7.00

Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis t...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 972 7 746 05012
Fax: 972 9 768 0244
Address:
85 Medinat ha-Yehudim Street, Herzliya, Israel
daddylongstocking
daddylongstocking Apr. 23 at 11:32 PM
$INCR dollar tomorrow or a pull back day and run up next week??? Either way I’m happy with it and wish I purchased more
0 · Reply
daddylongstocking
daddylongstocking Apr. 23 at 9:21 PM
$INCR what a great solid day
0 · Reply
futurewilltell
futurewilltell Apr. 23 at 7:49 PM
$INCR
1 · Reply
daddylongstocking
daddylongstocking Apr. 23 at 7:26 PM
$UCAR check out $INCR its been flying under the radar from most people and being doing well
0 · Reply
daddylongstocking
daddylongstocking Apr. 23 at 2:41 PM
$INCR watching close,
0 · Reply
kebrik
kebrik Apr. 23 at 2:02 PM
Today's movers: $ISPC, $AIXI, $NNBR, $REPL, and $INCR
0 · Reply
ChadTrades3
ChadTrades3 Apr. 10 at 1:36 PM
$INCR dead
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 8 at 12:03 AM
$INCR RSI: 42.04, MACD: -0.0255 Vol: 0.02, MA20: 0.77, MA50: 0.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
focafoca99
focafoca99 Mar. 3 at 10:36 PM
$INCR got a Nasdaq minimum bid notice
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 27 at 12:13 AM
$INCR Current Stock Price: $0.80 Contracts to trade: $2.5 INCR Apr 17 2026 Call Entry: $0.05 Exit: $0.08 ROI: 79% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on INCR
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement

Tue, 03 Mar 2026 16:46:00 -0500 - 7 weeks ago

InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million

Feb 19, 2026, 7:00 AM EST - 2 months ago

InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash of NIS 43 Million

InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation

Nov 3, 2025, 8:30 AM EST - 6 months ago

InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation

InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow

Oct 8, 2025, 9:40 AM EDT - 7 months ago

InterCure Reports First Half 2025 Results with NIS 130 Million in Revenue and Positive Operating Cash Flow

InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

Sep 19, 2025, 8:48 AM EDT - 7 months ago

InterCure Announces Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

May 1, 2025, 4:00 PM EDT - 1 year ago

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

Feb 12, 2025, 6:35 PM EST - 1 year ago

InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak

InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

Dec 20, 2024, 8:32 AM EST - 1 year ago

InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

Sep 14, 2024, 2:32 PM EDT - 1 year ago

Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

Aug 29, 2024, 6:03 PM EDT - 1 year ago

InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

Aug 28, 2024, 8:54 AM EDT - 1 year ago

InterCure Announces Expansion of its Strategic partnership with Cookies to Germany

InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference

May 22, 2024, 6:45 AM EDT - 2 years ago

InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

May 1, 2024, 8:27 AM EDT - 2 years ago

InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

Apr 1, 2024, 9:09 AM EDT - 2 years ago

InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

Mar 22, 2024, 11:58 AM EDT - 2 years ago

InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

Feb 23, 2024, 12:12 PM EST - 2 years ago

PESG Industry Updates: Germany's Cannabis Act and Its Impact on the Medical Cannabis Landscape

InterCure Provides an Update Regarding Nir Oz Facility

Feb 13, 2024, 4:46 PM EST - 2 years ago

InterCure Provides an Update Regarding Nir Oz Facility

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

Jan 31, 2024, 9:27 AM EST - 2 years ago

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

InterCure Wins Cannolam Arbitration Proceeding

Oct 31, 2023, 4:39 PM EDT - 2 years ago

InterCure Wins Cannolam Arbitration Proceeding

InterCure Provides an Update Regarding the Security Situation in Israel

Oct 17, 2023, 5:04 PM EDT - 2 years ago

InterCure Provides an Update Regarding the Security Situation in Israel

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

Aug 31, 2023, 7:45 PM EDT - 2 years ago

InterCure Announces Record Revenues First Half of 2023 with over 14% growth YOY

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

Jul 10, 2023, 5:00 PM EDT - 3 years ago

InterCure Ltd. Announces Proposed Voluntary Delisting from the Toronto Stock Exchange and shall continue to be listed on the NASDAQ and TASE

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

Jun 9, 2023, 5:18 PM EDT - 3 years ago

InterCure Provides an Update About The Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

May 15, 2023, 5:59 PM EDT - 3 years ago

InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

May 15, 2023, 5:45 PM EDT - 3 years ago

InterCure Announces Record Breaking First Quarter Revenues with 22% growth YOY

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

Apr 25, 2023, 7:19 PM EDT - 3 years ago

InterCure Informs That A Lawsuit Was Filed Against the Company by Minority Shareholders of Its Subsidiary

InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel

Mon, 24 Apr 2023 17:59:00 -0400 - 3 years ago

InterCure Informs That An Application To Approve a Class Action Against 26 Cannabis Companies in Israel, Including InterCure, Was Filed to The Court In Israel

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

Apr 20, 2023, 8:30 AM EDT - 3 years ago

InterCure Ltd. Partners with TYSON 2.0 in Israel, Australia, United Kingdom, Germany and Other EU Countries

InterCure Reschedules 2022 Full Year Results Conference Call

Apr 3, 2023, 3:27 PM EDT - 3 years ago

InterCure Reschedules 2022 Full Year Results Conference Call

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

Mar 31, 2023, 8:00 PM EDT - 3 years ago

InterCure Announces Record Fourth Quarter and Fiscal Year End 2022 Results

InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

Feb 14, 2023, 8:30 AM EST - 3 years ago

InterCure Files Lawsuit Against Cann Pharmaceuticals to Recover Funds Following Failed Merger

InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

Feb 1, 2023, 8:30 AM EST - 3 years ago

InterCure Announces the Termination of its Acquisition Agreement with Cann Pharmaceutical (dba Better)

InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

Dec 19, 2022, 8:30 AM EST - 3 years ago

InterCure Announces Exclusive International Partnership Agreement with Award Winning Cannabis Brand "Binske"

InterCure to Participate in Cowen 5th Annual Cannabis Conference

Dec 8, 2022, 9:30 AM EST - 3 years ago

InterCure to Participate in Cowen 5th Annual Cannabis Conference

InterCure Announces the Withdrawal of a Class Action Lawsuit against it

Mon, 05 Dec 2022 16:30:00 -0500 - 3 years ago

InterCure Announces the Withdrawal of a Class Action Lawsuit against it

Update regarding Better Transaction

Nov 23, 2022, 4:30 PM EST - 3 years ago

Update regarding Better Transaction

Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Nov 17, 2022, 8:17 AM EST - 3 years ago

Organigram and Intercure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

Nov 17, 2022, 8:00 AM EST - 3 years ago

Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both Companies

OGI

CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Nov 15, 2022, 11:18 AM EST - 3 years ago

CORRECTION and MULTIMEDIA UPDATE -- InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

Nov 15, 2022, 9:03 AM EST - 3 years ago

InterCure Announces Record Breaking Third Quarter Financial Results with 63% growth YOY and 6% QoQ growth

InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY

Nov 11, 2022, 8:32 AM EST - 3 years ago

InterCure Announces Record Preliminary Third Quarter Revenue of Over CAD$39 million – 63% Growth YoY

Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders

Sep 16, 2022, 4:30 PM EDT - 3 years ago

Intercure Ltd. Announces Voting Results from its Annual and Special Meeting of Shareholders

InterCure Reports Record Breaking Second Quarter Financial Results

Mon, 15 Aug 2022 09:15:00 -0400 - 4 years ago

InterCure Reports Record Breaking Second Quarter Financial Results

InterCure to Release its Q2 2022 Results and Hold a Conference Call

Thu, 11 Aug 2022 10:30:00 -0400 - 4 years ago

InterCure to Release its Q2 2022 Results and Hold a Conference Call

InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth

Thu, 21 Jul 2022 09:00:00 -0400 - 4 years ago

InterCure Reports Record Preliminary 2022 Second Quarter Revenue – More Than Double YoY and 9% QoQ Growth

InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria

Tue, 21 Jun 2022 08:40:00 -0400 - 4 years ago

InterCure and Cookies Launch Flagship Retail Location in Vienna, Austria

InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel

Thu, 02 Jun 2022 08:30:00 -0400 - 4 years ago

InterCure and Cookies Successfully Launch Flagship Pharmacy in Be'er Sheva, Israel

InterCure Begins 2022 with Record Breaking First Quarter Financial Results

Mon, 16 May 2022 17:50:00 -0400 - 4 years ago

InterCure Begins 2022 with Record Breaking First Quarter Financial Results

InterCure to Release its Q1 2022 Results and Hold a Conference Call

Mon, 16 May 2022 01:30:00 -0400 - 4 years ago

InterCure to Release its Q1 2022 Results and Hold a Conference Call

InterCure to Participate in Upcoming Investor Conferences in May 2022

Mon, 09 May 2022 11:20:00 -0400 - 4 years ago

InterCure to Participate in Upcoming Investor Conferences in May 2022

InterCure to Participate in A.G.P.'s Spring Consumer Cannabis Conference

May 3, 2022, 11:28 AM EDT - 4 years ago

InterCure to Participate in A.G.P.'s Spring Consumer Cannabis Conference

InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results

Apr 6, 2022, 12:39 AM EDT - 4 years ago

InterCure Reports Record Breaking Q4 and 2021 Results – Exceeded Preliminary Results

daddylongstocking
daddylongstocking Apr. 23 at 11:32 PM
$INCR dollar tomorrow or a pull back day and run up next week??? Either way I’m happy with it and wish I purchased more
0 · Reply
daddylongstocking
daddylongstocking Apr. 23 at 9:21 PM
$INCR what a great solid day
0 · Reply
futurewilltell
futurewilltell Apr. 23 at 7:49 PM
$INCR
1 · Reply
daddylongstocking
daddylongstocking Apr. 23 at 7:26 PM
$UCAR check out $INCR its been flying under the radar from most people and being doing well
0 · Reply
daddylongstocking
daddylongstocking Apr. 23 at 2:41 PM
$INCR watching close,
0 · Reply
kebrik
kebrik Apr. 23 at 2:02 PM
Today's movers: $ISPC, $AIXI, $NNBR, $REPL, and $INCR
0 · Reply
ChadTrades3
ChadTrades3 Apr. 10 at 1:36 PM
$INCR dead
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 8 at 12:03 AM
$INCR RSI: 42.04, MACD: -0.0255 Vol: 0.02, MA20: 0.77, MA50: 0.83 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
focafoca99
focafoca99 Mar. 3 at 10:36 PM
$INCR got a Nasdaq minimum bid notice
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 27 at 12:13 AM
$INCR Current Stock Price: $0.80 Contracts to trade: $2.5 INCR Apr 17 2026 Call Entry: $0.05 Exit: $0.08 ROI: 79% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 26 at 4:25 AM
$INCR RSI: 39.87, MACD: -0.0412 Vol: 0.03, MA20: 0.89, MA50: 1.01 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
ProfessorDman1
ProfessorDman1 Feb. 19 at 3:43 PM
$INCR should be over $1 .. great PR this morning … added some sub .90 cents
0 · Reply
ProfessorDman1
ProfessorDman1 Feb. 19 at 3:13 PM
$INCR should break $1 level ✍️🆙
0 · Reply
ProfessorDman1
ProfessorDman1 Feb. 19 at 3:08 PM
$KNRX from .80s to $3 225% $INCR next one to get volume .. sub $1 buying
0 · Reply
ProfessorDman1
ProfessorDman1 Feb. 19 at 2:49 PM
$INCR same chart 📊.. good PR out $KNRX 150% run ? ✍️✍️🆙
0 · Reply
DARKP00L
DARKP00L Feb. 19 at 12:19 PM
$INCR 07:07 on Feb. 19 2026 InterCure Posts Preliminary NIS 265M Revenue For 2025, An 11% YoY Rise, With 2H Revenue Nearly 20% Higher Than Prior Year #tradeideas
0 · Reply
ProfessorDman1
ProfessorDman1 Feb. 19 at 12:10 PM
InterCure Announces Preliminary Estimated 2025 Revenue of NIS 265 Million, Positive Adjusted EBITDA and Cash¹ of NIS 43 Million $INCR umm 🧐 watch over 1.10 could get a run 🏃‍♂️
0 · Reply
EntryStep
EntryStep Feb. 9 at 1:58 PM
$INCR Cannabis cultivator; operates in an oversupplied, unprofitable industry.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 3 at 10:45 AM
$INCR RSI: 38.54, MACD: -0.0603 Vol: 0.03, MA20: 0.95, MA50: 1.14 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Renato17
Renato17 Feb. 2 at 11:26 PM
$MSOS LIVE ON Z&A: Israel Market Outlook, Import & Export Potential @INTER_CURE $INCR $INCR.U @cronosgroup @mgorenst $CRON Pablo Zuanic @420Odysseus #Cannabis #cannabisindustry
0 · Reply
JesusWhale
JesusWhale Jan. 8 at 1:12 PM
$INCR down 35% on no fundamental changes or news. Company needs to release some sort of update or release 2H of 2025 earnings
0 · Reply